Carolinas Wealth Consulting’s LeMaitre Vascular LMAT Stock Holding History

Carolinas Wealth Consulting’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,040	Closed	-$507K	–	539
2025 Q1	$507K	Sell	6,040 -227	-4%	-$21.1K	0.11%	99
2024 Q4	$577K	Hold	6,267	–	–	0.11%	96
2024 Q3	$582K	Buy	6,267 +367	+6%	+$31.8K	0.11%	99
2024 Q2	$485K	Hold	5,900	–	–	0.09%	106
2024 Q1	$392K	Hold	5,900	–	–	0.08%	113
2023 Q4	$335K	Hold	5,900	–	–	0.07%	117
2023 Q3	$287K	Hold	5,900	–	–	0.07%	119
2023 Q2	$397K	Hold	5,900	–	–	0.08%	116
2023 Q1	$304K	Hold	5,900	–	–	0.06%	138
2022 Q4	$272K	Hold	5,900	–	–	0.06%	141
2022 Q3	$299K	Hold	5,900	–	–	0.08%	119
2022 Q2	$269K	Hold	5,900	–	–	0.07%	125
2022 Q1	$274K	Hold	5,900	–	–	0.06%	136
2021 Q4	$296K	Buy	5,900 +1,300	+28%	+$67.2K	0.06%	135
2021 Q3	$244K	Hold	4,600	–	–	0.06%	139
2021 Q2	$281K	Hold	4,600	–	–	0.06%	133
2021 Q1	$224K	Hold	4,600	–	–	0.05%	151
2020 Q4	$186K	Hold	4,600	–	–	0.05%	157
2020 Q3	$150K	Buy	+4,600	New	+$138K	0.05%	153

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Carolinas Wealth Consulting's LMAT Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 6,040 shares — an estimated $507K sold.

Carolinas Wealth Consulting first reported a position in LMAT in Q3 2020 and held it in 19 quarters. The position peaked at $582K in Q3 2024. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

Carolinas Wealth Consulting reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
Carolinas Wealth Consulting sold 6,040 LeMaitre Vascular shares in Q2 2025, an estimated $507K.
Carolinas Wealth Consulting first reported a position in LeMaitre Vascular in Q3 2020 and held it in 19 quarters.
Carolinas Wealth Consulting's LeMaitre Vascular position peaked at $582K in Q3 2024.
283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.